Altitude Cardiac Stress Index (ACSI) Calculator – High-Altitude Athletes

Clinical calculation support · Verify results before clinical use

Assessment inputs

Enter current conditions and athlete characteristics. This is an unvalidated heuristic, not a clinical prediction rule.

—Score
Sex contributes a point in the original heuristic only; this weighting is not validated.
For altitude-illness guidance, sleeping-altitude gain is especially relevant.
Interpret in relation to altitude, symptoms, measurement quality, and baseline.
The original heuristic adds points at ≥18 g/dL regardless of sex or altitude adaptation; this threshold is not validated for this purpose.

Clinical context and limitations

The Altitude Cardiac Stress Index (ACSI) shown here is a locally constructed heuristic that combines environmental, physiological, historical, and training variables. No peer-reviewed publication defining and validating this exact index, its weights, or its cutoffs was identified in the sources reviewed. Therefore, the score is descriptive only and must not be interpreted as a validated prediction of ischemia, arrhythmia, sudden cardiac death, or altitude illness.

What the evidence supports

  • Hypoxia, altitude reached, ascent profile, acclimatization, symptoms, and individual cardiovascular disease are relevant to exercise planning at altitude.
  • For altitude-illness prevention, recommendations generally focus on sleeping altitude and ascent rate; once above 3,000 m, guidance commonly recommends limiting sleeping-altitude gain to about 500 m/day and adding acclimatization days.
  • Prior altitude illness is clinically relevant. Sex alone has little, if any, role in predicting susceptibility to acute altitude illness.
  • SpO2 must be interpreted against altitude and clinical context; a single universal threshold is not established as a stand-alone cardiac safety cutoff for all athletes and elevations.

Original heuristic thresholds retained

ComponentOriginal scoring ruleEvidence status
Altitude<1,500 m: 0; <2,500: 1; <3,500: 3; <4,500: 5; otherwise 7Not validated as ACSI points
Ascent rate≤100: 0; ≤300: 1; ≤500: 2; >500 m/day: 3Thresholds differ from guideline-based sleeping-altitude advice
Acclimatization≥7 days: −2; ≥3 days: −1; otherwise 0Exact point deductions not validated
SpO2≥92%: 0; ≥88%: 2; ≥82%: 4; otherwise 6Not a universal altitude-adjusted clinical cutoff
Heart rate / SBPOriginal supplied thresholds retainedComposite weights not validated for altitude-athlete outcomes
History, cardiac disease, age, sex, hemoglobin, intensityOriginal supplied weights retainedWeights and overall score not validated

References

Cornwell WK III, et al.Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2021;10:e023225. DOI: 10.1161/JAHA.121.023225. PubMed record.
Centers for Disease Control and Prevention.High-Altitude Travel and Altitude Illness. CDC Yellow Book 2026. Guidance on acclimatization, ascent rate, risk factors, and altitude illness. Official CDC chapter.
Luks AM, Beidleman BA, Freer L, et al.Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update. Wilderness Environ Med. 2024. DOI: 10.1016/j.wem.2023.05.013. Publisher DOI page.
Clinical disclaimer: This calculator is an educational aid, not a validated clinical decision rule. It must not determine fitness to train, medical clearance, or treatment by itself. Known cardiac disease, chest pain, syncope, disproportionate dyspnea, cyanosis, confusion, resting hypoxemia, or clinical deterioration warrants appropriate medical assessment; severe symptoms at altitude may require stopping exertion and urgent descent/medical care. Individualized decisions should be made with a clinician familiar with sports cardiology and altitude exposure.